165 related articles for article (PubMed ID: 37062218)
1. Suppression of USP7 negatively regulates the stability of ETS proto-oncogene 2 protein.
Park HB; Min Y; Hwang S; Baek KH
Biomed Pharmacother; 2023 Jun; 162():114700. PubMed ID: 37062218
[TBL] [Abstract][Full Text] [Related]
2. USP7 regulates the ERK1/2 signaling pathway through deubiquitinating Raf-1 in lung adenocarcinoma.
Park HB; Hwang S; Baek KH
Cell Death Dis; 2022 Aug; 13(8):698. PubMed ID: 35948545
[TBL] [Abstract][Full Text] [Related]
3. Current and future directions of USP7 interactome in cancer study.
Park HB; Baek KH
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188992. PubMed ID: 37775071
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-specific protease 7 regulates nucleotide excision repair through deubiquitinating XPC protein and preventing XPC protein from undergoing ultraviolet light-induced and VCP/p97 protein-regulated proteolysis.
He J; Zhu Q; Wani G; Sharma N; Han C; Qian J; Pentz K; Wang QE; Wani AA
J Biol Chem; 2014 Sep; 289(39):27278-27289. PubMed ID: 25118285
[TBL] [Abstract][Full Text] [Related]
5. USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.
Saha G; Sarkar S; Mohanta PS; Kumar K; Chakrabarti S; Basu M; Ghosh MK
Oncogene; 2022 Nov; 41(47):5061-5075. PubMed ID: 36243803
[TBL] [Abstract][Full Text] [Related]
6. Protein phosphatase 2A regulated by USP7 is polyubiquitinated and polyneddylated.
Do HA; Baek KH
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35593311
[TBL] [Abstract][Full Text] [Related]
7. Preferential digestion of PCNA-ubiquitin and p53-ubiquitin linkages by USP7 to remove polyubiquitin chains from substrates.
Masuda Y; Kanao R; Kawai H; Kukimoto I; Masutani C
J Biol Chem; 2019 Mar; 294(11):4177-4187. PubMed ID: 30647135
[TBL] [Abstract][Full Text] [Related]
8. Molecular recognition of p53 and MDM2 by USP7/HAUSP.
Sheng Y; Saridakis V; Sarkari F; Duan S; Wu T; Arrowsmith CH; Frappier L
Nat Struct Mol Biol; 2006 Mar; 13(3):285-91. PubMed ID: 16474402
[TBL] [Abstract][Full Text] [Related]
9. USP7 small-molecule inhibitors interfere with ubiquitin binding.
Kategaya L; Di Lello P; Rougé L; Pastor R; Clark KR; Drummond J; Kleinheinz T; Lin E; Upton JP; Prakash S; Heideker J; McCleland M; Ritorto MS; Alessi DR; Trost M; Bainbridge TW; Kwok MCM; Ma TP; Stiffler Z; Brasher B; Tang Y; Jaishankar P; Hearn BR; Renslo AR; Arkin MR; Cohen F; Yu K; Peale F; Gnad F; Chang MT; Klijn C; Blackwood E; Martin SE; Forrest WF; Ernst JA; Ndubaku C; Wang X; Beresini MH; Tsui V; Schwerdtfeger C; Blake RA; Murray J; Maurer T; Wertz IE
Nature; 2017 Oct; 550(7677):534-538. PubMed ID: 29045385
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis.
Jiang L; Xiong J; Zhan J; Yuan F; Tang M; Zhang C; Cao Z; Chen Y; Lu X; Li Y; Wang H; Wang L; Wang J; Zhu WG; Wang H
J Biol Chem; 2017 Aug; 292(32):13296-13311. PubMed ID: 28655758
[TBL] [Abstract][Full Text] [Related]
11. USP7 substrates identified by proteomics analysis reveal the specificity of USP7.
Nie L; Wang C; Liu X; Teng H; Li S; Huang M; Feng X; Pei G; Hang Q; Zhao Z; Gan B; Ma L; Chen J
Genes Dev; 2022 Sep; 36(17-18):1016-1030. PubMed ID: 36302555
[TBL] [Abstract][Full Text] [Related]
12. C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site.
Ma J; Martin JD; Xue Y; Lor LA; Kennedy-Wilson KM; Sinnamon RH; Ho TF; Zhang G; Schwartz B; Tummino PJ; Lai Z
Arch Biochem Biophys; 2010 Nov; 503(2):207-12. PubMed ID: 20816748
[TBL] [Abstract][Full Text] [Related]
13. STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation.
Ye M; Tang Y; Tang S; Liu J; Wu K; Yao S; Sun Y; Zhou L; Deng T; Chen Y; Huang C; Tan W
Oncotarget; 2015 Oct; 6(33):34718-31. PubMed ID: 26460617
[TBL] [Abstract][Full Text] [Related]
14. USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.
Fan YH; Cheng J; Vasudevan SA; Dou J; Zhang H; Patel RH; Ma IT; Rojas Y; Zhao Y; Yu Y; Zhang H; Shohet JM; Nuchtern JG; Kim ES; Yang J
Cell Death Dis; 2013 Oct; 4(10):e867. PubMed ID: 24136231
[TBL] [Abstract][Full Text] [Related]
15. USP7 controls Chk1 protein stability by direct deubiquitination.
Alonso-de Vega I; Martín Y; Smits VA
Cell Cycle; 2014; 13(24):3921-6. PubMed ID: 25483066
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells.
Colland F; Formstecher E; Jacq X; Reverdy C; Planquette C; Conrath S; Trouplin V; Bianchi J; Aushev VN; Camonis J; Calabrese A; Borg-Capra C; Sippl W; Collura V; Boissy G; Rain JC; Guedat P; Delansorne R; Daviet L
Mol Cancer Ther; 2009 Aug; 8(8):2286-95. PubMed ID: 19671755
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase.
Faesen AC; Dirac AM; Shanmugham A; Ovaa H; Perrakis A; Sixma TK
Mol Cell; 2011 Oct; 44(1):147-59. PubMed ID: 21981925
[TBL] [Abstract][Full Text] [Related]
18. Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy.
Harakandi C; Nininahazwe L; Xu H; Liu B; He C; Zheng YC; Zhang H
Bioorg Chem; 2021 Nov; 116():105273. PubMed ID: 34474304
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity.
He Y; Li W; Lv D; Zhang X; Zhang X; Ortiz YT; Budamagunta V; Campisi J; Zheng G; Zhou D
Aging Cell; 2020 Mar; 19(3):e13117. PubMed ID: 32064756
[TBL] [Abstract][Full Text] [Related]
20. Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7.
Chavoshi S; Egorova O; Lacdao IK; Farhadi S; Sheng Y; Saridakis V
J Biol Chem; 2016 Mar; 291(12):6281-91. PubMed ID: 26786098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
